Sign in
4

Changes in Ownership

Sionna Therapeutics, Inc. Filed Acc 0001409601-26-000010

Options or other derivatives

  • Director acquired 17,340 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Clancy Paul J · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-17 Grant or award : show line 1 in the form Non-Qualified Stock Option (right to buy) +17,340 17,340 D
Loading xslF345X06/edgardoc.xml…